Stay updated on HMPL-689 in Lymphomas: Failed Standard - Clinical Trial
Sign up to get notified when there's something new on the HMPL-689 in Lymphomas: Failed Standard - Clinical Trial page.

Latest updates to the HMPL-689 in Lymphomas: Failed Standard - Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded Hubei as a study location under Locations; updated revision to v3.3.3 and removed the older Hubei Locations, HHS Vulnerability Disclosure, and the v3.3.2 tag.SummaryDifference0.2%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2 on the page (added v3.3.2 and removed v3.3.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1. The update does not introduce visible changes to study details or page layout.SummaryDifference0.1%

- Check57 days agoChange DetectedRemoved the government funding/operating status notice from the page, leaving only the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedMinor formatting and layout adjustments are visible in the Study Details page, with no changes to the study's inclusion/exclusion criteria, outcomes, or enrollment numbers. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check100 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference3%

Stay in the know with updates to HMPL-689 in Lymphomas: Failed Standard - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-689 in Lymphomas: Failed Standard - Clinical Trial page.